Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.
Solana Company
HSDTNASDAQ
Wall Street ScoreUnder review
$2.29USD+$0.06 (+2.69%)
The research page contains a warning that has not been mapped to a supported model interpretation. The company research remains available, but the complete score is withheld until the warning is reviewed.
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies.
How they make money
Solana Company operates as a digital asset treasury dedicated to acquiring and holding Solana tokens (SOL). The company aims to maximize SOL per share through strategic capital market activities, onchain opportunities, and staking treasury assets to earn rewards generated by network participation.
Products & services
The company holds a treasury of Solana (SOL) tokens and provides public market investors with direct exposure to Solana. It also maintains a legacy business developing and licensing non-implantable neurotechnology and medical devices.
Brands & revenue mix
No separate brand or brand-level revenue disclosure was confirmed in the reviewed sources. This does not mean the company has no brands.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
•Can HSDT maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
•How long can HSDT fund negative free cash flow using its current cash position before it may need more debt or new shares?
•How is HSDT likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
•What specifically needs to improve for HSDT to reach sustainable profitability?
•What future growth or profitability would be needed to justify HSDT's current valuation?
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
Volatility = How violently is it moving?
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for HSDT
Detected from reported data — verify before acting.
Debt service risk
Interest coverage is low (~-33.3x). Earnings may be strained to cover interest expense.
Community Sentiment
0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)
No personal call yet on HSDT.
Potential upside factors
+Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
+Direct exposure to Solana ecosystem.
+Ability to leverage capital markets for treasury growth.
Potential downside factors
−Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Asset Management industry.
−High volatility of Solana tokens.
−Concentration of assets in a single digital asset.
−Diluted weighted-average shares increased 3073.4% year over year.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdown
Debt
—
Debt Cost—
Debt Reduction YoY100.0%
Debt / Equity0.00x
Tap for breakdown →
Revenue
—
Revenue YoY100.6%
Revenue CAGR205.7%
Net Margin-1302.8%
Tap for breakdown →
Asset
—
Asset Growth YoY8480.7%
Liquidation/Share$2.84
Net Assets/MCap1.15x
Tap for breakdown →
Capital
—
Earnings Yield-102.8%
Buyback Yield0.0%
Debt Cost—
Tap for breakdown →
Management
—
ROIC-13.0%
ROE-94.9%
ROA-89.3%
Tap for breakdown →
Moat
—
EPS Growth—
FCF/Share Growth—
Rev/Share Growth-25.0%
Tap for breakdown →
Valuation
—
Intrinsic Value—
Value Reference—
MOS—
Tap for breakdown →
Buffett
—
Revenue—
Moat—
Valuation—
Tap for breakdown →
MOS
—
MOS %—
Value Reference—
Deep Discount Reference—
Tap for breakdown →
Financial
—
Interest Coverage-33.3x
ROIC-13.0%
FCF Yield-40.1%
Tap for breakdown →
Master
—
Financial—
Valuation—
Debt—
Tap for breakdown →
Resilience
—
Survival Years0.1 yrs
Current Ratio10.33x
FCF Margin-1018.7%
Tap for breakdown →
Was this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
YesNot yetDismiss
Score Changes
Score changes will appear once more historical records are available.
Price vs. Value
Valuation unavailable
Current Price
$2.29
Model Intrinsic Value
—
Difference
—
Margin of Safety
—
Value Reference: —
Deep Discount Reference: —
Intrinsic value is not currently available for this stock, so valuation can't be calculated.
Monetary values in USD. Share counts in raw units.
Large reported revenue change: +1057.1%
Revenue changed sharply from 2024 to 2025. This can reflect a real business change, acquisition, divestiture, discontinued operations, restatement, or reporting-basis change. Compare the underlying filing before treating it as normal growth or decline.
TTM may combine quarters from before and after the event, so its trend can also be distorted.
Income StatementBalance SheetCash Flow
AnnualQuarterlyTTM + Annual
All rows
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
Line Item
TTM
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
$12.1M
$6.0M
$520K
$644K
····
····
····
····
····
····
····
Cost of Revenue
$540K
$500K
$582K
$583K
····
····
····
····
····
····
····
Gross Profit
$11.5M
$5.5M
-$62K
$61K
····
····
····
····
····
····
····
Research & Development
$1.7M
$3.5M
$3.7M
$2.9M
····
····
····
····
····
····
····
SG&A Expenses
$34.0M
$23.1M
$10.1M
$9.3M
····
····
····
····
····
····
····
Operating Expenses
$35.7M
$26.6M
$13.8M
$12.5M
····
····
····
····
····
····
····
EBITDA
-$135.0M
-$39.6M
-$13.8M
-$12.1M
····
····
····
····
····
····
····
Operating Income
-$24.2M
-$21.1M
-$13.9M
-$12.4M
····
····
····
····
····
····
····
Interest Expense
$74K
$635K
$17K
$0.00
····
····
····
····
····
····
····
Income Before Tax
-$157.3M
-$40.9M
-$11.7M
-$8.8M
····
····
····
····
····
····
····
Income Tax Expense
$0.00
$0.00
$0.00
$0.00
····
····
····
····
····
····
····
Net Income
-$157.3M
-$40.9M
-$11.7M
-$8.8M
····
····
····
····
····
····
····
Basic EPS
$1.88
$-1.85
$-4.33
$-7.28
····
····
····
····
····
····
····
Basic Shares
78.25M
22.05M
2.71M
1.22M
····
····
····
····
····
····
····
Diluted Shares
78.25M
22.05M
2.71M
1.22M
····
····
····
····
····
····
····
Upgrade to Premium for up to 10 annual periods, where available.
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
Margins expanded
What Weakened
Cash position declined
Potential Score Impact
Positive indicators included revenue growth, net income margin. Pressure indicators included EPS growth, cash levels. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue increased 5774.4%. EPS declined 90.5%. Cash declined 40.0%. Net income margin improved by 21669.7 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Upgrade to Premium to unlock all earnings history.View plans
Government disclosed trading activity is available on the Smart Money directory. Filings may be delayed and may not represent complete current holdings.
Dividend HistoryShare
Dividend History
Dividend data is not available yet. Missing data does not mean this company pays no dividend.
Predictions & Historical PerformanceShare
Conservative Projected Values
3 Years
$———.——
Premium
5 Years
$———.——
Premium
10 Years
$———.——
Premium
Conservative Projection Rate
——%
Premium
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.